According to DexCom's latest financial reports and stock price the company's current number of shares outstanding is 386,600,000. At the end of 2023 the company had 386,600,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 0.38 B | 0.08% |
2022 | 0.38 B |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | 2,407,200,000 | 522.66% | ๐บ๐ธ USA |
Abbott Laboratories ABT | 1,734,076,358 | 348.55% | ๐บ๐ธ USA |
Medtronic MDT | 1,329,700,000 | 243.95% | ๐ฎ๐ช Ireland |
Becton Dickinson BDX | 290,113,000 | -24.96% | ๐บ๐ธ USA |
Edwards Lifesciences EW | 607,000,000 | 57.01% | ๐บ๐ธ USA |
Tandem Diabetes Care
TNDM | 65,117,000 | -83.16% | ๐บ๐ธ USA |
QuidelOrtho QDEL | 66,900,000 | -82.70% | ๐บ๐ธ USA |
West Pharmaceutical WST | 74,300,000 | -80.78% | ๐บ๐ธ USA |